Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

February 28, 2025

Conditions
Neuroendocrine NeoplasmChinaWomenCervical CancerCervical Lesion
Trial Locations (9)

350001

RECRUITING

Fujian Maternity and Child Health Hospital, Fuzhou

363000

RECRUITING

Zhangzhou affiliated Hospital of Fujian Medical University, Zhangzhou

Unknown

RECRUITING

Fujian Provincial Hospital, Fuzhou

RECRUITING

Ningde Mindong Hospital, Ningde

RECRUITING

Putian City first Hospital, Putian

RECRUITING

The Second Affiliated Hospital of Fujian Medical University, Quanzhou

RECRUITING

Maternal and Child Health Hospital of Hubei Province, Wuhan

RECRUITING

Xiangya Hospital, Central South University, Changsha

RECRUITING

Jiangxi maternal and Child Health Hospital, Nanchang

All Listed Sponsors
lead

Fujian Maternity and Child Health Hospital

OTHER